VolitionRX Ltd’s filing revealed that its Director Innes Guy Archibald acquired Company’s shares for reported $50000.0 on Aug 05 ’25. In the deal valued at $0.64 per share,78,125 shares were bought. As a result of this transaction, Innes Guy Archibald now holds 966,814 shares worth roughly $0.67 million.
Then, Reynolds Cameron John bought 78,125 shares, generating $50,000 in total proceeds. Upon buying the shares at $0.64, the President and CEO now owns 2,609,847 shares.
Before that, Reynolds Cameron John bought 12,500 shares. VolitionRX Ltd shares valued at $7,372 were divested by the President and CEO at a price of $0.59 per share. As a result of the transaction, Reynolds Cameron John now holds 2,331,722 shares, worth roughly $1.61 million.
H.C. Wainwright initiated its VolitionRX Ltd [VNRX] rating to a Buy in a research note published on April 08, 2025; the price target was $2.50. A number of analysts have revised their coverage, including The Benchmark Company’s analysts, who decreased its forecast for the stock in early February from “a Buy” to “a Hold”. Cantor Fitzgerald started covering the stock on March 10, 2021. It rated VNRX as “an Overweight”.
Price Performance Review of VNRX
On Friday, VolitionRX Ltd [AMEX:VNRX] saw its stock jump 7.94% to $0.69. Over the last five days, the stock has gained 8.24%. VolitionRX Ltd shares have risen nearly 31.86% since the year began. Nevertheless, the stocks have risen 15.82% over the past one year. While a 52-week high of $0.94 was reached on 06/23/25, a 52-week low of $0.40 was recorded on 05/19/25.
Levels Of Support And Resistance For VNRX Stock
The 24-hour chart illustrates a support level at 0.6249, which if violated will result in even more drops to 0.5550. On the upside, there is a resistance level at 0.7599. A further resistance level may holdings at 0.8250.
How much short interest is there in VolitionRX Ltd?
A steep rise in short interest was recorded in VolitionRX Ltd stocks on 2025-07-31, dropping by -0.1 million shares to a total of 0.19 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 0.29 million shares. There was a decline of -53.64%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 16, 2018 when Maxim Group began covering the stock and recommended ‘”a Buy”‘ rating along with a $6 price target.
